Foster C S, Stavrou P, Zafirakis P, Rojas B, Tesavibul N, Baltatzis S
Uveitis and Immunology Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston 02114, USA.
Am J Ophthalmol. 1999 Jul;128(1):31-7. doi: 10.1016/s0002-9394(99)00139-7.
To report a series of patients with uveitis and cataract who had undergone cataract extraction with posterior chamber intraocular lens implantation and who subsequently had the intraocular lens removed because of progressive intraocular damage from inflammation.
Review of the records of 19 patients after removal of a posterior chamber intraocular lens. The decision to perform surgery was based on standard criteria after evaluation at a single uveitis referral center.
The complications leading to intraocular lens removal were perilental membrane (eight eyes), chronic low-grade inflammation not responding to anti-inflammatory treatment (eight eyes), and cyclitic membrane resulting in hypotony and maculopathy (three eyes). After intraocular lens removal the inflammation subsided and the visual acuity improved or stabilized in 14 of the 19 eyes. The causes of further reduction in the visual acuity of the other five patients were macular edema (two patients), maculopathy resulting from hypotony (one patient), retinal detachment (one patient), and vitreous hemorrhage (one patient).
Intraocular lens implantation can form part of a reasonable plan for visual rehabilitation of patients with uveitic cataract, but inclusion of an intraocular lens in the plan is not always in the overall long-term best interest of the patient. Intraocular lens removal may salvage useful vision for patients who continue to exhibit complications secondary to uveitis after cataract extraction and intraocular lens implantation, provided the intraocular lens is removed before irreparable damage has been done to macula or optic nerve.
报告一系列患有葡萄膜炎和白内障的患者,这些患者接受了白内障摘除联合后房型人工晶状体植入术,随后因炎症导致的进行性眼内损害而取出了人工晶状体。
回顾19例后房型人工晶状体取出术后患者的病历。手术决策基于在单一葡萄膜炎转诊中心评估后的标准标准。
导致人工晶状体取出的并发症包括晶状体周膜(8只眼)、对抗炎治疗无反应的慢性低度炎症(8只眼)以及导致低眼压和黄斑病变的睫状膜(3只眼)。取出人工晶状体后,19只眼中有14只眼的炎症消退,视力提高或稳定。另外5例患者视力进一步下降的原因分别是黄斑水肿(2例)、低眼压导致的黄斑病变(1例)、视网膜脱离(1例)和玻璃体积血(1例)。
人工晶状体植入可以成为葡萄膜炎性白内障患者视力康复合理计划的一部分,但在计划中纳入人工晶状体并不总是符合患者的整体长期最佳利益。对于白内障摘除联合人工晶状体植入术后仍因葡萄膜炎出现并发症的患者,只要在黄斑或视神经受到不可修复的损害之前取出人工晶状体,取出人工晶状体可能挽救有用视力。